Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Neoplasms
Interventions
DRUG

PET tracer (BAY94-9392)

A radioactive dose of 300 MBq of the study drug with a total quantity of \</= 0.1 mg will be administered as slow intravenous bolus injection over up to 60 seconds

Trial Locations (1)

94305

Stanford

Sponsors
All Listed Sponsors
lead

Life Molecular Imaging SA

INDUSTRY